Abstract
RATIONALE: The ability of CD40 signaling to regulate B cell growth, survival, differentiation, and Ig class switching involves changes in gene expression. CD40 ligation activates the Rel/NF-κB transcription factors, which are major regulators of immune and inflammatory responses and potentially activates both type 1 (p105/p50) and type 2 (p100/p52) NF-κB activation pathways. Using primary B cells, we investigated the contribution of NFκb activation on CD40 mediated IL-13 receptor expression, using BAY11, an IkappaB-alpha phosphorylation inhibitor.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
